Live feed
Filing
SC 13D/A
SC 13D/A0001178913-14-003191·Abramson Herbert
Schedule 13D ownership disclosure
Aptose Biosciences Inc., (formerly LORUS THERAPEUTICS INC.)
Security class unavailable · CUSIP: 03835T101
Event date: 2014-10-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001178913-14-003191
- Form type
- SC 13D/A
- Filer
- Abramson Herbert
- CIK
- CIK 1354542
- Filed
- Oct 21, 2014
- Reporting period
- Oct 14, 2014
- Description
- Schedule 13D beneficial ownership